A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
October 19, 2021 10:03 ET | Odyssey Group International
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) --   Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving...
The Importance of Testing for Traumatic Brain Injuries Before It's Too Late
October 06, 2021 11:30 ET | Cambre & Associates
ATLANTA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Traumatic brain injury (TBI) results from an impact to the head. Injuries can be mild or more serious and leave bruising, torn tissue, internal/external...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
September 22, 2021 08:39 ET | Odyssey Group International
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical...
logo-brainhq-hi-res-hori.png
Study: Brain Training Can Address Persistent Issues from Traumatic Brain Injuries
September 14, 2021 08:00 ET | Posit Science
SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Researchers at New York University published a study among patients with cognitive deficits from Traumatic Brain Injuries showing that...
Lrg_Foundation_Horiz1_RGB.png
Craig Hospital Awarded 10th Spinal Cord Injury Model Systems Grant
September 13, 2021 12:17 ET | Craig Hospital
Englewood, Colo. , Sept. 13, 2021 (GLOBE NEWSWIRE) -- Craig Hospital, a world-renowned neurorehabilitation and research hospital for people who have sustained spinal cord and/or brain injuries was...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference
September 09, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Approved to Start Human Trial to Treat Concussion        
September 01, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch
August 30, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment
August 06, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial
August 04, 2021 09:25 ET | Odyssey Group International
IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...